Clinical Trials · NCT02917005
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Hamdy A. Azim
- Enrollment
- 160
- Start date
- May 2019
- Locations
- 1 site, South Africa
- Primary endpoint
- Progression free survival